A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care.
This study concludes that the newly produced Cm-Au-PLGA-PSPE composite would be a promising alternative in treating human gliomas and associated wounds with increased biomedical applications.
PMID: 31411066 [PubMed - in process]
Source: Artificial Cells, Nanomedicine and Biotechnology - Category: Biotechnology Tags: Artif Cells Nanomed Biotechnol Source Type: research
More News: Biotechnology | Brain | Brain Cancers | Brain Tumor | Burns | Cardiology | Glioma | Heart | Heart Transplant | Kidney Transplant | Liver | Liver Transplant | Lung Transplant | Nanotechnology | Neurology | Nurses | Nursing | Study | Urology & Nephrology